-
, neurodegenerative, autoimmune and infectious diseases. Leveraging innovative platforms such as novel biosensors, gene switches, genetic closed-loop circuits, and chemical structures that interface with and actuate
-
targeting cancer as well as metabolic, neurodegenerative, autoimmune and infectious diseases. Leveraging innovative platforms such as novel biosensors, gene switches, genetic closed-loop circuits, and
-
to dissect key signaling components linking immune perception to metabolic regulation Phosphoproteomics and targeted metabolite analysis to identify metabolic switches activated during microbial exposure
Enter an email to receive alerts for switch "https:" positions